These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 17414513)

  • 1. Prostate cancer prevention.
    Nelson WG
    Curr Opin Urol; 2007 May; 17(3):157-67. PubMed ID: 17414513
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of inflammation and infection in the pathogenesis of prostate carcinoma.
    Wagenlehner FM; Elkahwaji JE; Algaba F; Bjerklund-Johansen T; Naber KG; Hartung R; Weidner W
    BJU Int; 2007 Oct; 100(4):733-7. PubMed ID: 17662075
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inflammation and prostate cancer.
    Sugar LM
    Can J Urol; 2006 Feb; 13 Suppl 1():46-7. PubMed ID: 16526982
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prostate carcinogenesis and inflammation: emerging insights.
    Palapattu GS; Sutcliffe S; Bastian PJ; Platz EA; De Marzo AM; Isaacs WB; Nelson WG
    Carcinogenesis; 2005 Jul; 26(7):1170-81. PubMed ID: 15498784
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genome-wide linkage analysis of TMPRSS2-ERG fusion in familial prostate cancer.
    Hofer MD; Kuefer R; Maier C; Herkommer K; Perner S; Demichelis F; Paiss T; Vogel W; Rubin MA; Hoegel J
    Cancer Res; 2009 Jan; 69(2):640-6. PubMed ID: 19147579
    [TBL] [Abstract][Full Text] [Related]  

  • 6. ETS gene fusions in prostate cancer: from discovery to daily clinical practice.
    Tomlins SA; Bjartell A; Chinnaiyan AM; Jenster G; Nam RK; Rubin MA; Schalken JA
    Eur Urol; 2009 Aug; 56(2):275-86. PubMed ID: 19409690
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Estrogen and prostate cancer: an eclipsed truth in an androgen-dominated scenario.
    Carruba G
    J Cell Biochem; 2007 Nov; 102(4):899-911. PubMed ID: 17786930
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 5alpha-androstane-3alpha,17beta-diol supports human prostate cancer cell survival and proliferation through androgen receptor-independent signaling pathways: implication of androgen-independent prostate cancer progression.
    Yang Q; Titus MA; Fung KM; Lin HK
    J Cell Biochem; 2008 Aug; 104(5):1612-24. PubMed ID: 18320593
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Distinct classes of chromosomal rearrangements create oncogenic ETS gene fusions in prostate cancer.
    Tomlins SA; Laxman B; Dhanasekaran SM; Helgeson BE; Cao X; Morris DS; Menon A; Jing X; Cao Q; Han B; Yu J; Wang L; Montie JE; Rubin MA; Pienta KJ; Roulston D; Shah RB; Varambally S; Mehra R; Chinnaiyan AM
    Nature; 2007 Aug; 448(7153):595-9. PubMed ID: 17671502
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 5alpha-reductase inhibitors in benign prostatic hyperplasia and prostate cancer risk reduction.
    Rittmaster RS
    Best Pract Res Clin Endocrinol Metab; 2008 Apr; 22(2):389-402. PubMed ID: 18471794
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genetic variability in inflammation pathways and prostate cancer risk.
    Sun J; Turner A; Xu J; Grönberg H; Isaacs W
    Urol Oncol; 2007; 25(3):250-9. PubMed ID: 17483024
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inflammation, atrophy, and prostate carcinogenesis.
    De Marzo AM; Nakai Y; Nelson WG
    Urol Oncol; 2007; 25(5):398-400. PubMed ID: 17826659
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prostate inflammation and its potential impact on prostate cancer: a current review.
    Haverkamp J; Charbonneau B; Ratliff TL
    J Cell Biochem; 2008 Apr; 103(5):1344-53. PubMed ID: 17955503
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dietary influences on endocrine-inflammatory interactions in prostate cancer development.
    Ho E; Boileau TW; Bray TM
    Arch Biochem Biophys; 2004 Aug; 428(1):109-17. PubMed ID: 15234275
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genetic and microenvironmental implications in prostate cancer progression and metastasis.
    Alberti C
    Eur Rev Med Pharmacol Sci; 2008; 12(3):167-75. PubMed ID: 18700688
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Focal degeneration of basal cells and the resultant auto-immunoreactions: a novel mechanism for prostate tumor progression and invasion.
    Man YG; Gardner WA
    Med Hypotheses; 2008; 70(2):387-408. PubMed ID: 17658698
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epigenetic mechanisms in the biology of prostate cancer.
    Schulz WA; Hoffmann MJ
    Semin Cancer Biol; 2009 Jun; 19(3):172-80. PubMed ID: 19429481
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Histopathological evidence for an association of inflammation with ductal pin-like lesions but not with ductal adenocarcinoma in the prostate of the noble rat.
    Bernoulli J; Yatkin E; Laakso A; Anttinen M; Bosland M; Vega K; Kallajoki M; Santti R; Pylkkänen L
    Prostate; 2008 May; 68(7):728-39. PubMed ID: 18302197
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The discovery of common recurrent transmembrane protease serine 2 (TMPRSS2)-erythroblastosis virus E26 transforming sequence (ETS) gene fusions in prostate cancer: significance and clinical implications.
    Shah RB; Chinnaiyan AM
    Adv Anat Pathol; 2009 May; 16(3):145-53. PubMed ID: 19395877
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prostate cancer prevention: past, present, and future.
    Fleshner N; Zlotta AR
    Cancer; 2007 Nov; 110(9):1889-99. PubMed ID: 17893870
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.